THERAPEUTIC USE OF CHIMERIC AND MARKED ANTIBODIES PROVIDED AGAINST A DIFFERENTIATING ANTIGEN, THE EXPRESSION OF WHICH IS LIMITED TO HUMAN B LYMPHOCYTES FOR THE TREATMENT OF B-CELL LYMPHOMA

摘要

Disclosed herein is an immunologically active, chimeric anti-CD20 antibody for use as a medicament, which antibody is capable of substantial B-cell depletion when administered to a subject.